Aztronaz 1g
Aztreonam (1gm)
About this product
Targeted gram-negative coverage against E. coli, Klebsiella, and Pseudomonas for serious UTI, respiratory, intra-abdominal, gynaecological, skin, and bloodstream infections.
Overview
Aztronaz 1g is a monobactam antibiotic built for serious Gram-negative infections — urinary tract, lower respiratory tract, intra-abdominal, gynaecological, and bloodstream infections. Because cross-reactivity with other beta-lactams is rare, it gives clinicians a dependable option in patients with a documented penicillin or cephalosporin allergy.
Indications
Related Products
Cilbactam 1.5
Ampicillin (1gm) + Sulbactam (500mg)
Broad single-agent coverage against gram-positive, gram-negative, and anaerobic infections, including skin, intra-abdominal, and gynaecological infections such as PID and endometritis.
Mertazo 1.5
Meropenem (1gm) + Tazobactam (500mg)
Dependable broad-spectrum coverage for resistant hospital infections, including HAP/VAP, complicated intra-abdominal infections, complicated UTI/pyelonephritis, and severe sepsis pending culture guidance.
Partner With Schemic Concepts
Engineer better health outcomes with precision-driven pharmaceuticals
Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it